Melatonin decreases cell proliferation and transformation in a melatonin receptor-dependent manner

Cancer Letters

Volumn 151, Issue 2, 2000, Pages 133-143

  Jones, Marla P ^a   Melan, Melissa A ^a   Witt Enderby, Paula A ^a  

^a DUQUESNE UNIVERSITY   (United States)

Author keywords

Cancer; Desensitization; Human mt1 and MT2 melatonin receptors; Melatonin; Proliferation; Transformation

Indexed keywords

CYCLIC AMP; MELATONIN; MELATONIN RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CARCINOGENESIS; CELL COUNT; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; GENE EXPRESSION; GENE TRANSFER; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BINDING SITES; CELL COUNT; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIC AMP; DNA; FORSKOLIN; HUMANS; MELATONIN; MICE; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 0034646905     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00394-8     Document Type: Article

References (42)

1. Molis T.M., Spriggs L.L., Hill S. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol. Endocrinol. 8:1994;1681-1690.
2. Furuya Y., Yamamoto K., Kohno N., Ku Y., Saitoh Y. 5-Fluorouracil attenuates an oncostatic effect of melatonin on estrogen-sensitive human breast cancer cell (MCF7). Cancer Lett. 81:1994;95-98.
3. Ying S.W., Niles L.P., Crocker C. Human malignant melanoma cells express high affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur. J. Pharmacol. 246:1993;89-96.
4. Brzezinski A. Melatonin in humans. N Engl. J. Med. 336:1997;186-195.
5. Bartsch H., Bartsch C. Effect of melatonin on experimental tumors under different photoperiods and times of administration. J. Neural Transm. 52:1981;269-279.
6. Bartsch C., Bartsch H., Karenovics A., Franz H., Peiker G., Mecke D. Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size. J. Pineal Res. 23:1997;53-58.
7. Bartsch C., Kvetnoy I., Kvetnaia T., Bartsch H., Molotkov A., Franz H. Nocturnal urinary 6-sulfatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumor cells show strong positive correlations in patients with gastrointestinal and lung cancer. J. Pineal Res. 23:1997;90-96.
8. Lissoni P., Viviani S., Bajetta E., Buzzoni R., Barreca A., Mauri R., Resentini M., Morabito F., Esposti D., Esposti G., Fraschini F. A clinical study of the pineal gland activity in oncologic patients. Cancer. 57:1986;837-842.
9. Lissoni P., Crispino S., Barni S., Sormani A., Brivio F., Pelizzoni F., Brenna A., Bratina G., Tancini G. Pineal gland and tumor cell kinetics: serum levels of melatonin in relation to Ki-67 labeling rate in breast cancer. Oncology. 47:1990;275-277.
10. Dogliotti L., Berruti A., Buniva T., Torta M., Bottini A., Tampellini M., Terzolo M., Faggiuolo R., Angeli A. Melatonin and human cancer. J. Steroid Biochem. Mol. Biol. 37:1990;983-987.
11. Maestroni G.J.M., Conti A. Melatonin in human breast cancer tissue: association with nuclear grade and estrogen receptor status. Lab. Invest. 75:1996;557-561.
12. Tamerkin L., Cohen M., Roselle D., Reichert C., Lippman M., Chabner B. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene induced mammary tumors in the rat. Cancer Res. 41:1981;4432-4436.
13. Blask D.E., Hill S.M., Orstead K.M., Massa J.S. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenz(alpha)-anthracene-induced (DMBA)-induced mammary tumorigenesis. J. Neural Transm. 67:1986;125-138.
14. Philo R., Berkowitz A.S. Inhibition of dunning tumor growth by melatonin. J. Urol. 139:1988;1099-1102.
15. Cos S., Verduga R., Fernandez-Viadero C., Megias M., Crespo D. Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture. Neurosci. Lett. 266:1996;113-116.
16. Cini G., Coronnello M., Mini E., Neri B. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett. 125:1998;51-59.
17. Mayo J.C., Sainz R.M., Uria H., Antolin I., Esteban M.M., Rodriguez C. Inhibition of cell proliferation: a mechanism likely to mediate the prevention of neuronal cell death by melatonin. J. Pineal Res. 25:1998;12-18.
18. Blask D.E., Hill S.M. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J. Neural. Transm. 21:1986;433-449.
19. Cos S., Sanchez-Barcelo E.J. Melatonin inhibition of MCF-7 human breast-cancer cell growth: influence of cell proliferation rate. Cancer Lett. 93:1995;207-212.
20. Carossino A.M., Lombardi A., Matucci-Cerinic M., Pignone A., Cagnoni M. Effect of melatonin on normal and sclerodermic skin fibroblast proliferation. Clin. Exp. Rheumatol. 14:1996;493-498.
21. Tsutsui T., Taguchi S., Tanaka Y., Barrett J.C. 17β-estradiol, diethylstilbestrol, tamoxifen, toremifene, and ICI 164,384 induce morphological transformation and aneuploidy in cultured Syrian hamster embryo cells. Int. J. Cancer. 70:1997;188-193.
22. Cos S., Fernandez R., Guezmes A., Sanchez-Barcelo E.J. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 58:1998;4383-4390.
23. Pierpaoli W., Dall'ara A., Pedrinins E., Regelson W. The pineal control of aging he effects of melatonin and pineal grafting on the survival of older mice. Ann. N. Y. Acad. Sci. USA. 621:1991;291-313.
24. Reppert S.M., Weaver D.R., Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron. 13:1994;1177-1185.
25. Morgan P.J., Barrett P., Howell H.E., Helliwell R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem. Int. 24:1994;101-146.
26. Witt-Enderby P.A., Dubocovich M.L. Characterization and regulation of the human ML1A melatonin receptor stably expressed in chinese hamster ovary cells. Mol. Pharmacol. 50:1996;166-174.
27. Witt-Enderby P.A., Masana M.I., Dubocovich M. Physiological exposure to melatonin supersensitizes the cyclic adenosine 3′,5′-monophosphate-dependent signal transduction cascade in chinese hamster ovary cells expressing the human mt1 melatonin receptor. Endocrinology. 139:1998;3064-3071.
28. Reppert S.M., Godson C., Mahle C.D., Weaver D.R., Slaugenhaupt S.A., Gusella J.F. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc. Natl. Acad. Sci. USA. 92:1995;8734-8738.
29. Ram P.T., Kiefer T., Silverman M., Song Y., Brown G.M., Hill S.M. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol. Cell. Endocrinol. 141:1998;53-64.
30. Baldwin W.S., Barrett J.C. Melatonin: receptor-mediated events that may affect breast and other steroid hormone-dependent cancers. Mol. Carcinog. 21:1998;149-155.
31. Finocchiaro L.M.E., Glikin G.C. Intracellular melatonin distribution in cultured cell lines. J. Pineal Res. 24:1998;22-34.
32. Benitez-King G., Anton-Tay F. Calmodulin mediates melatonin cytoskeletal effects. Experientia. 49:1993;635-641.
33. Jainchill J., Aaronson S.A., Todaro G.J. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4:1969;549-553.
34. Gutkind J.S., Novotny E.A., Brann M.R., Robbins K. Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc. Natl. Acad.Sci. USA. 88:1991;4703-4707.
35. Westphal R.S., Sanders-Bush E. Differences in agonist-independent and -dependent 5-hydroxytryptamine 2c receptor-mediated cell division. Mol. Pharmacol. 49:1996;474-480.
36. Godson C., Reppert S.M. The mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology. 138:1997;397-404.
37. Dubocovich M.L. Melatonin receptors: are there multiple subtypes. Trends Pharmacol. Sci. 16:1995;50-56.
38. Cos S., Recio J., Sanchez-Barcelo E.J. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin. Life Sci. 58:1996;811-816.
39. Najid A., Ratinaud M.-H. Comparative studies of steroidogenesis inhibitors (econazole, ketoconazole) on human breast cancer MCF-7 cell proliferation by growth experiments, thymidine incorporation and flow cytometric DNA analysis. Tumori. 77:1991;385-390.
40. Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J.D. The cell-division cycle, in: Molecular Biology of the Cell. 3rd Edition :1994;863-910 Garland Publishing, Inc, New York.
41. Guh J.H., Hwang T.L., Ko F., Chueh S., Lai M., Teng C. Antiproliferative effect in human prostatic smooth muscle cells by nitric oxide donor. Mol. Pharmacol. 53:1998;467-474.
42. Hazlerigg D.G., Thompson M., Hastings M.H., Morgan P.J. Regulation of mitogen-activated protein kinase in the pars tuberalis of the ovine pituitary: interactions between melatonin, insulin-like growth factor-1, and forskolin. Endocrinology. 137:1996;210-218.